News
Ibrutinib: Innovation für Blutkrebs-Patienten
www.aerzteblatt.de
Dr. med. Martin Dreyling, Universitätsklinikum München, ist Ibrutinib nicht einfach „just another drug“, sondern ein „weiterer Durchbruch in der Behandlung von ...
Neue Strategien mit Oxaliplatin | PZ – Pharmazeutische Zeitung
www.pharmazeutische-zeitung.de
Da diffuse großzellige Lymphome stark proliferieren, seien sie sehr chemosensitiv, sagte Privatdozent Dr. Martin Dreyling aus München. Als etabliertes ...
Neue Studie zur Behandlung des Mantelzell-Lymphoms
www.innovations-report.de
Martin Dreyling von der Medizinischen Klinik III am Klinikum der LMU. Und jetzt haben sich die Aussichten von rückfälligen Patienten nochmals ...
Wyeth: Temsirolimus verlängert progressionsfreies Überleben beim ...
www.bionity.com
Die Rationale für die Wirksamkeit von Temsirolimus beim fortgeschrittenen Mantelzell-Lymphom ergibt sich durch die Pathophysiologie des seltenen Lymphoms: Das MCL ist durch die Chromosomentranslokation t(11;14) q(13;32) gekennzeichnet, ...
Netzwerk-Profile
WikiGenes - Martin Dreyling
www.wikigenes.org
Martin Dreyling. Department of Internal Medicine III. Klinikum der Universität München. Campus Grosshadern. Germany. [-muenchen.de.
Interessen
ESMO Guideline for Mantle Cell Lymphoma
www.medscape.com
ESMO recently published its guideline for mantle cell lymphoma. Author Martin Dreyling highlights some of the key, evidence-based recommendations.
lastFM: Martin Dreyling, University Hospital Grosshaden, Munich music,...
Listen to music from Martin Dreyling, University Hospital Grosshaden, Munich like ONCOLOGY: Combinations and Targeted Agents: Better Survival in Mantle Cell...
The 'Fab Five' Rock Lymphoma
www.medscape.com
Dr Martin Dreyling reviews recent data in lymphoma indicating that the command performance of five biologic agents do all but lock the door on chemotherapy and...
Business-Profile
patentbuddy: Martin Dreyling
ROCHE GLYCART AG
Experten zum Mantelzell-Lymphom und zur CLL - Deutsche...
www.krebsgesellschaft.de
Hier stellen sich Prof. Martin Dreyling und Dr. Barbara Eichhorst vor, ausgewiesen ausgewiesene Experten zum Mantelzell-Lymphom und zur CLL.
Firmen-Mitarbeiter
Prof. Martin Dreyling - About | Lymphoma Hub
lymphomahub.com
Martin Dreyling is Professor of Medicine and head of the lymphoma programme in the Department of Medicine III, University Hospital Groβhadern, Ludwig ...
Bücher
Dreyling: Indolente Non-Hodgkin-Lymphome
von Martin Dreyling, Uni-Med, Bremen, 2009, Gebundene Ausgabe
Moderne Therapieregime in der Behandlung niedrig maligner Lymphome, der CLL und des multiplen Myeloms
von Martin Dreyling, Uni-Med, Bremen, 2011, Gebundene Ausgabe
NHL - Diagnostik und Therapie. State of the Art 2007
von Martin Dreyling, Agileum Gesundheitsakademie, 2007, Taschenbuch
Dokumente zum Namen
SCHATTENBLICK - KREBS/996: Patientensicherheit in klinischen Studien...
www.schattenblick.de
... Behandlungsstandards festlegen", erklärt Professor Dr. Martin Dreyling, Koordinator des Europäischen Mantelzell-Lymphom-Netzwerks und ...
Dreyling, Martin [WorldCat Identities]
worldcat.org
Rare lymphomas by Martin Dreyling( ) 14 editions published between and in English and held by 304 WorldCat member libraries worldwide
[PDF] Martin Dreyling - European Medicines Agency - Free ...
docspike.com
Download Martin Dreyling - European Medicines Agency...
Wissenschaftliche Veröffentlichungen
Mantle cell lymphoma - ScienceDirect
www.sciencedirect.com
Martin Dreyling is head of the lymphoma section at the Department of Internal Medicine III, University Hospital Grosshadern. In addition, he is coordinator of the ...
Treatment of limited stage follicular lymphoma with Rituximab...
bmccancer.biomedcentral.com
Martin Dreyling (Munich), Marianne Engelhard (Essen), Bertram Glass (Hamburg ), Michael Kneba (Kiel), Heinz Share on LinkedIn
Mutations prevent programmed cell death -- ScienceDaily
www.sciencedaily.com
Programmed cell death is a mechanism that causes defective and potentially harmful cells to destroy themselves. It serves a number of purposes in the body,...
New drug shows promise in treating indolent non-Hodgkin lymphomas
www.sciencedaily.com
A new drug, idelalisib, shows efficacy in treating patients with relapsed indolent non-Hodgkin lymphomas.
Veröffentlichungen allgemein
Behandlung follikulärer Lymphome | SpringerLink
link.springer.com
Das follikuläre Lymphom ist das häufigste indolente Lymphom. Es zeichnet sich durch einen langen, chronischen Verlauf aus. Eine Heilung ist bislang nicht...
Rituximab maintenance therapy in follicular lymphoma | SpringerLink
link.springer.com
Follicular lymphomas are considered incurable, but most patients survive for many years. The introduction of rituximab into the treatment of malignant lymp
Video & Audio
Prof Martin Dreyling at ASH 2014: Novel biologic … · O …
oncologytube.com
At the American Society of Hematology (ASH) Annual Meeting, Prof Martin Dreyling (Ludwig-Maximilians University of Munich, Munich, ...
New therapy aspects for myeloid chronic lymphoma - ecancer
ecancer.org
▶Dr Simon Rule, Prof Martin Dreyling, Prof Olivier Hermine ... in New Orleans, USA, Dr Simon Rule, Derriford ...
The future management of mantle cell lymphoma - ecancer
ecancer.org
Dr Simon Rule - Derriford Hospital, Plymouth, UK and Dr Martin Dreyling - Ludwig Maximilians-University, Munich, Germany. MCL is an ...
Research To Practice | An Integrated Approach to Oncology Education
www.researchtopractice.com
Proceedings from Part 1 of a 2-part satellite symposia series during the 57th ASH Annual Meeting. Featuring perspectives from Drs Martin Dreyling, Christopher.
Artikel & Meinungen
Wikipedia: Martin Dreyling – Wikipedia
Martin Heinz Dreyling (* in Wuppertal) ist ein deutscher Hämatologe und Onkologe und Professor an der Ludwig-Maximilians-Universität München.
Wikipedia: Lymphom – Wikipedia
Wolfgang Hiddemann, Martin Dreyling, Harald Stein (Hrsg.): Lymphome – Neue Erkenntnisse und Therapiestrategien. Georg Thieme Verlag, 2004, ISBN ...
Ibrutinib paves way to a brighter future in MCL | Nature Reviews...
www.nature.com
“Both ibrutinib and temsirolimus are registered for relapsed MCL in Europe, based on mostly phase II studies,” explains Martin Dreyling. “Thus ...
Sonstiges
Martin Dreyling - Google Scholar Citationsscholar.google.com › citations
scholar.google.com
Martin Dreyling. Professor of Medicine, University of Munich. Verified email at med.uni-muenchen.de. lymphoma. ArticlesCited by ...
US A1 - Combination therapy of an afucosylated cd20...
patents.google.com
The present invention is directed to the combination therapy of an afucosylated anti-CD20 antibody with fludarabine and/or mitoxantrone for the treatment...
Martin Dreyling - Google Scholar Citations
scholar.google.se
ดัชนีการอ้างอิง, ทั้งหมด, ตั้งแต่ปี การอ้างอิงดัชนี h, 60, 49. ดัชนี i10, 216,
Follikuläres Lymphom — Onkopedia
www.onkopedia.com
Autoren vorheriger Versionen: Christian Buske, Michael Herold, Mathias Rummel, Martin Dreyling. 1 Definition und Basisinformationen.
DGIM 2013: Prof. Dr. Martin Dreyling
www.dgim-onlinekongress.de
Dr. Martin Dreyling. Prof. Dr. Martin Dreyling. Kontakt. Leitung Molekulare und Pathogenese maligner Lymphome. LMU - Klinikum der Universität München, ...
Genetik - Lymphome: Prof.Dr.med. Martin Dreyling - bio-m.org
db.bio-m.org
Genetik - Lymphome: Prof.Dr.med. Martin Dreyling. Website: Tags: Human Medicine, Molecular Medicine, Genetics. Keywords: Molecular Medicine. Instruments ...
WO A2 - Modified antigen binding molecules with altered cell...
patents.google.com
Applicant, Glycart Biotechnology Ag, Pablo Umana, Ekkehard Mossner , Roche Glycart Ag, Humanized anti-cdcp1 antibodies US *, 7 júlí 2011, Martin Dreyling, Combination therapy of an afucosylated ...
CA A1 - Polytherapie a base d'un anticorps afucosyle anti-cd20...
patents.google.com
The present invention is directed to the combination therapy of an afucosylated anti-CD20 antibody with fludarabine and/or mitoxantrone for the treatment of...
DGIM 2013: Prof. Dr. Martin Dreyling: PET-CT contra
www.dgim-onlinekongress.de
Sponsoren Wir bedanken uns für die Unterstützung bei folgenden Unternehmen:
Researcher: Martin H Dreyling in Publications - Dimensions
app.dimensions.ai
Re-imagining discovery and access to research: grants, datasets, publications, citations, clinical trials, patents and policy documents in one place.
Prof Martin DREYLING - Orphanet
www.orpha.net
Pr Martin DREYLING. Activities registered with Orphanet : Coordinator of expert centre - Clinical expert - Principal investigator of clinical trial - Coordinator of ...
Martin Dreyling | Videos & Research | VJHemOnc
www.vjhemonc.com
Martin Dreyling speaks exclusively to VJHemOnc , The Video Journal of Hematological Oncology. Watch interviews and discussions with Martin Dreyling here.
Prof. Dr. med. Martin Dreyling - SHG „Halle“www.shg-halle.de › onkologen › 16-prof-dr-med-martin-dreyling
www.shg-halle.de
Kontakt. Position: Leitender Oberarzt. Adresse: Medizinischen Klinik III am Klinikum der Universität München Station G10B : München
Prof. Dr. med. Martin Dreyling - hematooncology.com -...
www.hematooncology.com
hematooncology bietet für Ärzte hochwertige Zusammenfassungen der wichtigsten hämatoonkologischen Kongresse. Zahlen und Fakten werden von erfahrenen Experten...
Q&A With Martin Dreyling, MD, PhD, on Non-Hodgkin Lymphoma Research...
www.cancertherapyadvisor.com
Dr Dreyling discusses research presented at the ASH Annual Meeting likely to have a clinical impact among patients with NHL.
Q&A With Martin Dreyling, MD, PhD, on Non-Hodgkin ...
www.cancertherapyadvisor.com
Dr Dreyling, MD, PhD, professor of medicine at the University of Munich Hospital in Germany, is a renowned hematologist with expertise in ...
Nodales Marginalzonen Lymphom — Onkopedia
www.onkopedia.com
Prof. Dr. med. Martin Dreyling. Klinikum der Universität München Med. Klinik und Poliklinik III Großhadern München.
Combination therapy of an afucosylated CD20 antibody with fludarabine...
www.patentsencyclopedia.com
Inventors: Martin Dreyling (Planegg, DE) Daniel Alexander Heinrich mg/ml (Roche, Glycart) [0142] Combinations partners [0143] 1.
» ESH-EHA 32nd Tutorial on Lymphoid Malignancies ESH - European...
www.esh.org
– Mantle cell lymphoma Martin Dreyling (Germany) – Tutored clinical cases & question time – Self-evaluation cases ...
sortiert nach Relevanz / Datum